Elron Ventures Ltd

Elron Ventures Ltd

296.40
ILA
+11.30
(+3.96%)
25.70BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
0.01
0.03
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
0.6
2.87
0.08
-0.9
-0.86
-0.53
-0.6
-0.41
0.11
1.34
-0.16
0.43
0.18
- -
Free Cash Flow per Basic Share
-0.36
-0.34
-0.71
-0.55
-0.61
-0.63
-0.38
-0.26
-0.11
-0.11
-0.07
-0.07
-0.04
- -
Dividend per Share
- -
3.7
- -
0.5
- -
- -
- -
- -
- -
0.66
- -
0.79
0.27
- -
Book Value per Share
6.08
5.24
5.32
3.95
3.12
2.6
1.79
1.42
1.93
2.62
2.48
2.09
1.96
1.99
Tangible Book Value per Share
5.93
5.13
4.73
3.36
2.53
2.02
1.39
1.35
1.87
2.57
2.42
2.04
1.91
1.93
Basic Weighted Avg Shares
30
30
30
30
30
30
37
43
49
52
52
53
53
51
Sales/Revenue/Turnover
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
-11,988.66
-2,739.04
-2,482.68
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
1
- -
- -
1
1
- -
1
- -
- -
- -
- -
Net Income, GAAP
18
85
2
-27
-25
-16
-22
-18
5
70
-8
23
9
- -
Effective Tax Rate (%)
- -
30.89
32.21
- -
- -
- -
- -
- -
22.09
1.5
- -
16.68
1.15
- -
Profit Margin (%)
18,489.69
22,859.36
275.7
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Working Capital
137
155
145
94
74
51
49
32
79
77
109
92
55
63
LT Debt
- -
- -
- -
1
1
- -
2
1
10
10
10
10
7
10
Total Equity
200
193
206
162
126
111
103
79
126
152
142
125
126
113
Return on Invested Capital (%)
- -
1.31
6.64
- -
- -
- -
- -
- -
21.67
49.72
- -
20.56
10.74
- -
Return on Capital (%)
- -
35.11
-1.04
- -
- -
- -
- -
- -
-2.44
54.12
- -
14.58
3.14
- -
Return on Common Equity (%)
10.46
50.79
1.56
-19.46
-24.26
-18.56
-28.92
-25.62
6.8
58.78
-6.16
18.84
8.64
- -

Capital Structure

USD

•

in mil. unless spec.
Sep'23
Dec'23
Jun'24
ST Debt
- -
- -
- -
LT Borrowings
9
9
9
LT Finance Leases
- -
1
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
52
52
52
Market Capitalization
64
91
68

Working Capital

USD

•

in mil. unless spec.
Sep'23
Dec'23
Jun'24
Total Current Assets
54
116
69
Cash, Cash Equivalents & STI
52
50
65
Accounts Receivable, Net
1
- -
4
Inventories
- -
- -
- -
Total Current Liabilities
5
7
6
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-2.4%
12.49%
0.29%
Free Cash Flow
-17.26%
-24.05%
-44.94%
Net Income, GAAP
-72.6%
98.01%
-58.78%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
-65.57%

Semi-annual Revenue

USD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Semi-annual Earnings Per Share

USD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.43
2025
- -
- -
0.18
2026
- -
- -
- -

Semi-annual Dividends Per Share

USD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.79
2025
- -
- -
0.27
2026
- -
- -
- -

Company Description

CEO
Yaron Elad
Full Time Employees
5
Sector
Finance
Industry
Investment managers
Address
ToHa Tower Tel Aviv TA Israel 6744320
IPO Date
Jan 1, 1975
Business
Elron Ventures Ltd (TASE: ELRN) is an Israel-based operational holding company and venture capital firm that invests in and builds early-stage technology companies, primarily in cybersecurity, enterprise software (SaaS), deep tech, defense tech, and select medical devices. The company provides capital, strategic guidance, board representation, and operational support to its portfolio companies, including product development, go-to-market strategies, and partnerships; it realizes value through exits, public offerings, or distributions to shareholders. Elron operates through subsidiaries such as Rafael Development Corporation Ltd. (RDC, 50.1% owned jointly with Rafael Advanced Defense Systems Ltd.), RDSeed Ltd., and El CISO Ltd. (managing partner of CyberFuture, its Global CISO investment alliance); core holdings include cybersecurity firms like IronScales (anti-phishing), Sixgill (dark web intelligence), Cynerio (healthcare cyber protection), Scribe Security (software supply chain security), Red Access (secure web access), Cyvers (DeFi security), and Breeze (threat prediction); enterprise software such as Sayata (AI insurance platform), OpenLegacy (legacy modernization APIs), Zengo (crypto wallet), Tamnoon (cloud risk remediation), and Creednz (fraud prevention); and medical/deep tech like Notal Vision (AMD diagnostics), BrainsGate (neurological stimulation), Nitinotes (obesity treatment), Atlantium (UV water disinfection), Wonder Robotics (drone awareness), Edge (ad tech), Audioburst (AI audio), and N-Drip (energy-free irrigation). Elron focuses on Israeli startups with global potential, leveraging its investment platform that includes ideation support, Rafael IP commercialization rights, CyberFuture for CISO-led cyber investments (e.g., Astrix, Prompt, Entitle), an advisory board of industry executives, and networks of "Elronists" (prior entrepreneurs) and international contacts. Founded in 1962 and headquartered at ToHa Tower in Tel Aviv, Israel, with a New York office, Elron has historically incubated over 30 companies generating combined annual revenues of approximately $5 billion, including notable past exits like Given Imaging (to Covidien), Medingo (to Roche), Cloudyn (to VMware), and SecuredTouch (to Ping Identity). In September 2024, Arieli EL (part of the Arieli Group) acquired a 59.14% controlling stake from Discount Investment Corporation Ltd. for $53.2 million, including Elron's 50% in RDC, to accelerate growth in cyber, B2B software, and civil technologies via Arieli's global ecosystem; recent exits include Canonic (2023) and CartiHeal (2024, orthopedic implants); the company reports three exits in 2025 year-to-date, shifting strategy toward deep-tech/defense-tech with "exit mentality" via enhanced Rafael ties, while distributing dividends of $26.5 million (2024) and pursuing further payouts from exits.